Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Abiraterone Acetate × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 192 Breast 5 Tumor-Agnostic 2 Thoracic 2 Head & Neck 1 Gynecologic 1 Endocrine 1

Conditions

Cushing Syndrome 1 Adrenocortical Carcinoma 1

Interventions

Everolimus 55 lutetium Lu 177 dotatate 49 Magnetic Resonance Spectroscopy 33 Cisplatin 26 Temozolomide 25 pembrolizumab 24 gallium Ga 68 dotatate 21 Octreotide 21 Nivolumab 21 lanreotide 20 cabozantinib 18 3-Iodobenzylguanidine 18 Specimen Handling 17 Capecitabine 17 Etoposide 16 pasireotide 15 lenvatinib 15 Sunitinib 15 Paclitaxel 15 dabrafenib 14 Carboplatin 14 Bevacizumab 14 trametinib 13 surufatinib 13 Surgical Procedures, Operative 11 Ipilimumab 11 Injections 11 Doxorubicin 11 177Lu-octreotide, DOTA(0)-Tyr(3)- 11 Sorafenib 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03145285 2017-05-10

ABACUS

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Phase 2 Unknown

Cushing Syndrome, Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡